0001104659-17-032106.txt : 20170512 0001104659-17-032106.hdr.sgml : 20170512 20170512075912 ACCESSION NUMBER: 0001104659-17-032106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170511 FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 POOR FARM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540-1715 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 101 POOR FARM ROAD CITY: PRINCETON STATE: NJ ZIP: 08540-1715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Selman Renee CENTRAL INDEX KEY: 0001677942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36464 FILM NUMBER: 17836440 MAIL ADDRESS: STREET 1: 1111 LOCUST STREET - NUMBER 7H CITY: PHILADELPHIA STATE: PA ZIP: 19107 4 1 a4.xml 4 X0306 4 2017-05-11 0 0001261249 AGILE THERAPEUTICS INC AGRX 0001677942 Selman Renee 101 POOR FARM ROAD PRINCETON NJ 08540 0 1 0 0 Chief Commercial Officer Common Stock 2017-05-11 4 P 0 53333 3.68 A 53333 D The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.46 to $3.75, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Scott M. Coiante, Attorney-in-Fact 2017-05-12